Biocartis Group Stock Forecast - Triple Exponential Smoothing

BCART Stock  EUR 0.29  0.00  0.00%   
The Triple Exponential Smoothing forecasted value of Biocartis Group NV on the next trading day is expected to be 0.29 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Biocartis Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Biocartis Group stock prices and determine the direction of Biocartis Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Biocartis Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Triple exponential smoothing for Biocartis Group - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Biocartis Group prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Biocartis Group price movement. However, neither of these exponential smoothing models address any seasonality of Biocartis Group NV.

Biocartis Group Triple Exponential Smoothing Price Forecast For the 25th of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Biocartis Group NV on the next trading day is expected to be 0.29 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.
Please note that although there have been many attempts to predict Biocartis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biocartis Group's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Biocartis Group Stock Forecast Pattern

Backtest Biocartis GroupBiocartis Group Price PredictionBuy or Sell Advice 

Biocartis Group Forecasted Value

In the context of forecasting Biocartis Group's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biocartis Group's downside and upside margins for the forecasting period are 0.29 and 0.29, respectively. We have considered Biocartis Group's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.29
0.29
Expected Value
0.29
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Biocartis Group stock data series using in forecasting. Note that when a statistical model is used to represent Biocartis Group stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
As with simple exponential smoothing, in triple exponential smoothing models past Biocartis Group observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Biocartis Group NV observations.

Predictive Modules for Biocartis Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biocartis Group NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocartis Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.290.290.29
Details
Intrinsic
Valuation
LowRealHigh
0.240.240.32
Details

Other Forecasting Options for Biocartis Group

For every potential investor in Biocartis, whether a beginner or expert, Biocartis Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biocartis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biocartis. Basic forecasting techniques help filter out the noise by identifying Biocartis Group's price trends.

Biocartis Group Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocartis Group stock to make a market-neutral strategy. Peer analysis of Biocartis Group could also be used in its relative valuation, which is a method of valuing Biocartis Group by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biocartis Group NV Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Biocartis Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Biocartis Group's current price.

Biocartis Group Market Strength Events

Market strength indicators help investors to evaluate how Biocartis Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocartis Group shares will generate the highest return on investment. By undertsting and applying Biocartis Group stock market strength indicators, traders can identify Biocartis Group NV entry and exit signals to maximize returns.

Pair Trading with Biocartis Group

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.

Moving against Biocartis Stock

  1.0INGA ING Groep NVPairCorr
The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Biocartis Stock

Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.